ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

APGE Apogee Therapeutics Inc

37.535
1.17 (3.20%)
Last Updated: 08:49:27
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Apogee Therapeutics Inc APGE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.17 3.20% 37.535 08:49:27
Open Price Low Price High Price Close Price Previous Close
36.70 36.70 37.68 36.37
more quote information »

Recent News

Date Time Source Heading
6/07/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/07/202415:02EDGAR2Form 8-K - Current report
5/30/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/30/202419:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
5/28/202406:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
5/28/202406:35EDGAR2Form 8-K - Current report
5/28/202406:30GLOBEApogee Therapeutics Expands Board of Directors with the..
5/23/202406:30GLOBEApogee Therapeutics to Participate in Upcoming June Investor..
5/15/202415:01GLOBEApogee Announces Dosing of First Patient in Phase 2 Atopic..
5/13/202406:26EDGAR2Form S-8 - Securities to be offered to employees in employee..
5/13/202406:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202406:05EDGAR2Form 8-K - Current report
5/13/202406:00GLOBEApogee Therapeutics Highlights Pipeline Progress and Reports..
5/06/202407:00GLOBEApogee Therapeutics to Participate at the 2024 Bank of..
3/25/202406:00GLOBEApogee Therapeutics Announces First Participants Dosed in..
3/12/202415:01GLOBEApogee Therapeutics, Inc. Announces Closing of Upsized..
3/11/202405:01EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
3/07/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
3/07/202417:49GLOBEApogee Therapeutics, Inc. Announces Pricing of Upsized $420..
3/07/202417:27EDGAR2Form S-1MEF - Registration adding securities to prior Form..
3/05/202415:23GLOBEApogee Therapeutics, Inc. Announces Proposed..
3/05/202415:05EDGAR2Form S-1 - General form for registration of securities under..
3/05/202407:15EDGAR2Form 8-K - Current report
3/05/202405:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/05/202405:11EDGAR2Form 8-K - Current report
3/05/202405:10GLOBEApogee Therapeutics Provides Pipeline Progress and Reports..
3/05/202405:00GLOBEApogee Announces Positive Interim Results from Phase 1..
3/04/202415:01GLOBEApogee to Host Conference Call and Webcast to Report Interim..
1/02/202406:30GLOBEApogee Therapeutics to Present at the 42nd Annual J.P...
12/20/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202306:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202306:41EDGAR2Form 8-K - Current report
11/13/202306:30GLOBEApogee Highlights Corporate Progress and Reports Third..
10/30/202307:00GLOBEApogee Therapeutics to Participate in Upcoming November..
9/27/202307:42GLOBEApogee Announces Two Abstracts Accepted for Presentation at..
9/14/202306:30GLOBEApogee Therapeutics to Participate at the 2023 Stifel..
8/29/202307:00PRNUSParagon Therapeutics Recognizes Key Milestones and..
8/28/202306:30GLOBEApogee Highlights Corporate Progress and Reports Second..
8/21/202306:30GLOBEApogee Therapeutics Appoints Mark C. McKenna, Healthcare..
8/07/202306:30GLOBEApogee Announces First Participants Dosed Ahead of Schedule..
8/02/202306:30GLOBEApogee Therapeutics to Participate in Upcoming August..
7/18/202315:01GLOBEApogee Therapeutics, Inc. Announces Closing of Upsized..